Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation and structural evaluation by NMR and mass spectrometry (Q77966025)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 1999

Language	Label	Description	Also known as
English	Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation and structural evaluation by NMR and mass spectrometry	scientific article published on 01 April 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation and structural evaluation by NMR and mass spectrometry (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Bacillus licheniformis

1 reference

[Val7]lichenysin G13

1 reference

[Val7]lichenysin G15

1 reference

[Ile2,4]lichenysin G15

1 reference

2-[(3S,6R,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3-[(2S)-butan-2-yl]-25-[(7S)-7-methylnonyl]-6,15,18-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

2-[(3S,6R,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3-[(2S)-butan-2-yl]-25-(8-methylnonyl)-6,15,18-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

2-[(3S,6R,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3-[(2S)-butan-2-yl]-6,15,18-tris(2-methylpropyl)-25-(10-methylundecyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

1 reference

[Val7]lichenysin G14

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-25-(8-methylnonyl)-6,15,18-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3,12-bis[(2S)-butan-2-yl]-6,15,18-tris(2-methylpropyl)-25-[(9S)-9-methylundecyl]-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-25-[(7S)-7-methylnonyl]-6,15,18-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-6,15,18-tris(2-methylpropyl)-25-(10-methylundecyl)-2,5,8,11,14,17,20,23-octaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

[Ile4]lichenysin G15

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-6,15,18-tris(2-methylpropyl)-25-[(9S)-9-methylundecyl]-2,5,8,11,14,17,20,23-octaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3,12,18-tris[(2S)-butan-2-yl]-6,15-bis(2-methylpropyl)-25-(10-methylundecyl)-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3,12,18-tris[(2S)-butan-2-yl]-6,15-bis(2-methylpropyl)-25-[(9S)-9-methylundecyl]-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

1 reference

1 reference

2-[(3S,6R,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3-[(2S)-butan-2-yl]-25-(9-methyldecyl)-6,15,18-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

1 reference

2-[(3S,6R,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3-[(2S)-butan-2-yl]-6,15,18-tris(2-methylpropyl)-25-[(9S)-9-methylundecyl]-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-3,12-bis[(2S)-butan-2-yl]-6,15,18-tris(2-methylpropyl)-25-(10-methylundecyl)-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

2-[(3S,6S,9S,12S,15R,18S,21S,25R)-21-(3-amino-3-oxopropyl)-25-(9-methyldecyl)-6,15,18-tris(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-3,12-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-9-yl]acetic acid

1 reference

1 reference

based on heuristic

inferred from title

author name string

I Grangemard

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J M Bonmatin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J Bernillon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

B C Das

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Peypoux

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1999

1 reference

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/52/4/52_4_363/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.52.363?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

363-373

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.52.363?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Precursor directed biosynthesis of aureobasidins

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.49.676

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

[Ala4]surfactin, a novel isoform from Bacillus subtilis studied by mass and NMR spectroscopies

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Properties of the biosurfactant produced by Bacillus licheniformis strain JF-2

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Lipopeptides with improved properties: structure by NMR, purification by HPLC and structure-activity relationships of new isoleucyl-rich surfactins

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Chrysospermins, New Peptaibol Antibiotics from Apiocrea chrysosperma Ap101

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.48.977

Isolation and characterization of a new variant of surfactin, the [Val7]surfactin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Structural analysis ofBacillus licheniformis 86 surfactant

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Identification of amino acid substitutions in the lipopeptide surfactin using 2D NMR spectroscopy

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Inhibition of acyl-CoA: cholesterol acyltransferase by isohalobacillin, a complex of novel cyclic acylpeptides produced by Bacillus sp. A1238

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Bacillomycin; an antibiotic from Bacillus subtilis active against pathogenic fungi

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

ComA-dependent transcriptional activation of lichenysin A synthetase promoter in Bacillus subtilis cells.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Characterization of the surfactin synthetase multi-enzyme complex

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Purification of antifungal lipopeptides by reversed-phase high-performance liquid chromatography

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Biosurfactants from Bacillus licheniformis: structural analysis and characterization

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.363

Identifiers

10.7164/ANTIBIOTICS.52.363

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395272%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77966025&oldid=2127375002"